Previous 10 | Next 10 |
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. For further details see: XLV: Healthcare Dashboard For November
Projecting Innoviva's earnings is pretty easy. For professional investors, it's even easier. Yet the stock fluctuates like crazy, and often, the highest volatility comes when earnings have just been revealed. The sometimes evident disconnect between market action and certain funda...
Innoviva (INVA): Q3 GAAP EPS of $0.26.Revenue of $88.69M (+34.9% Y/Y)Shares +1.6% AH.Press Release For further details see: Innoviva reports Q3 results
Royalties increased by 33% to $92.2 million in the third quarter of 2020, compared to the same quarter in 2019. Invested an additional $12.5 million into the common stock and warrants of Entasis Therapeutics Holding Inc. (NASDAQ: ETTX), a leader in anti-infectives development. ...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. For further details see: Healthcare: XLV Survey For October
This article series shows every month a dashboard with aggregate industry metrics in healthcare. Most of the companies used to calculate these metrics are holdings of the Health Care Select Sector SPDR ETF ( XLV ). Therefore, this is also a top-down survey of XLV. Shortcut If you are use...
Here are 5 small-cap trades that made us money last week. However, I believe that after the recent tech selloff the market should find it easier to rally higher again. Happy Monday, my smart and savvy friends. Another summer has come and gone. It's been a challenging year. Lockdown...
The FDA has approved a new indication for GlaxoSmithKline (NYSE: GSK ) and Innoviva's (NASDAQ: INVA ) Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to its current licen...
New asthma indication for Trelegy Ellipta introduces an important option for patients to the current treatment paradigm GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Elli...
A special purpose acquisition company (SPAC) is a publicly traded shell company that raises capital with the intent of acquiring a private business. SPACs have become an intriguing alternative for companies that want to go public because they allow that to happen much faster than with an init...
News, Short Squeeze, Breakout and More Instantly...
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strate...